TransMedics Reports Third Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
- ServiceNow (NOW) Misses Q3 EPS by 2c, Beats on Revenue; Offers Q4 Revenue Guidance
- Oracle sets $225 billion revenue target for FY30 at investor day
- Rivian shares slip ahead of Thursday earnings release
- S&P Global explores potential separation of Capital IQ business
- SpaceX stock drops amid spaceport lawsuit, debt concerns
TransMedics Group (TMDX) Misses Q3 EPS by 11c
November 9, 2021 4:42 PM ESTTransMedics Group (NASDAQ: TMDX) reported Q3 EPS of ($0.47), $0.11 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $5.4 million versus the consensus estimate of $6.35 million.
GUIDANCE:
TransMedics Group sees FY2021 revenue of $27.6-28.6 million.
For earnings history and earnings-related data on TransMedics Group (TMDX) click here.
... More


